Hidekatsu Wakizaka Selected Research

Ligands

11/2017	In Vivo Monitoring for Regional Changes of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Pilocarpine-Induced Epileptic Rat Brain by Small-Animal PET.
11/2012	Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidekatsu Wakizaka Research Topics

Disease

14	Neoplasms (Cancer) 10/2021 - 06/2010
8	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2010
4	Central Nervous System Diseases (CNS Diseases) 01/2019 - 10/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2013
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
2	Neuroinflammatory Diseases 01/2021 - 11/2017
2	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2014
2	Brain Diseases (Brain Disorder) 01/2018 - 01/2016
2	Inflammation (Inflammations) 01/2014 - 10/2012
1	Residual Neoplasm 10/2021
1	Stroke (Strokes) 01/2021
1	Ischemia 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Obesity 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2017
1	Food Addiction 09/2017
1	Body Weight (Weight, Body) 01/2017
1	Colonic Neoplasms (Colon Cancer) 04/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Hypercapnia 01/2016
1	Neurologic Manifestations (Neurological Manifestations) 01/2016
1	Fibrosis (Cirrhosis) 11/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015
1	Carcinogenesis 10/2014
1	Huntington Disease (Huntington's Disease) 04/2014
1	Lung Diseases (Lung Disease) 09/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
4	IntegrinsIBA 12/2020 - 09/2013
4	metabotropic glutamate receptor type 1IBA 11/2017 - 10/2012
2	Red Fluorescent ProteinIBA 10/2021 - 04/2016
2	Cetuximab (Erbitux)FDA Link 10/2021 - 06/2018
2	Neuroprotective AgentsIBA 01/2021 - 01/2018
2	ElacridarIBA 02/2019 - 02/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2017 - 10/2012
2	acetamideIBA 11/2017 - 01/2014
2	LigandsIBA 11/2017 - 11/2012
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 10/2012
2	isobutyric acidIBA 05/2015 - 10/2012
2	Peptides (Polypeptides)IBA 04/2014 - 09/2013
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	AntibodiesIBA 01/2021
1	1-methyl-L-tryptophanIBA 01/2021
1	SAR127303IBA 01/2021
1	Monoacylglycerol LipasesIBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020
1	Multidrug Resistance-Associated Protein 2IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	2- (4,5- dihydro- 1H- imidazol- 2- yl)- 1- methyl- 1H- indoleIBA 01/2019
1	AntioxidantsIBA 01/2018
1	Pilocarpine (Ocusert)FDA LinkGeneric 11/2017
1	Ghrelin ReceptorsIBA 09/2017
1	regorafenibIBA 04/2016
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	Fluorouracil (Carac)FDA LinkGeneric 04/2016
1	ThymidineIBA 04/2016
1	Therapeutic UsesIBA 04/2016
1	alpha-SynucleinIBA 01/2016
1	RacloprideIBA 01/2016
1	Flumazenil (Romazicon)FDA LinkGeneric 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2015
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2015
1	deoxyuridine triphosphateIBA 05/2015
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 05/2015
1	Integrin alpha5beta1IBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 10/2014
1	Oncogene Proteins (Oncogene Protein)IBA 10/2014
1	N-methylbenzamideIBA 10/2014
1	cyclic arginine-glycine-aspartic acid peptideIBA 04/2014
1	Penicillamine (Cuprimine)FDA Link 01/2014
1	CopperIBA 01/2014
1	Chelating AgentsIBA 01/2014
1	multidrug resistance-associated protein 1IBA 09/2013
1	RAFT-RGDIBA 09/2013
1	XenobioticsIBA 09/2013
1	cyclamIBA 09/2013
1	Arachidonic Acid (Vitamin F)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	AndrogensIBA 01/2013
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2021 - 10/2012
3	Precision Medicine 01/2021 - 01/2014
3	Radiotherapy 12/2020 - 04/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 06/2010
1	Operative Surgical Procedures 10/2021
1	Immunotherapy 01/2021
1	Computer-Assisted Surgery (Image Guided Surgery) 10/2020
1	Radioimmunotherapy 06/2018
1	Oral Administration 01/2017
1	Adjuvant Chemotherapy 04/2016
1	Lasers (Laser) 01/2016
1	Aftercare (After-Treatment) 05/2015
1	Heterologous Transplantation (Xenotransplantation) 09/2013